Nanoparticle Asphaltene Inhibitor Composition for Extended Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing asphaltene inhibitors require continuous treatment methods that are inefficient and costly, leaving untreated portions of the reservoir and necessitating extensive infrastructure, which is not easily retrofitted for sudden asphaltene formation.

Innovation Solution

Development of nanoparticles containing a carrier material and asphaltene inhibitor that provide a controlled, extended release of the inhibitor over time, allowing for efficient treatment of subterranean formations and wells using existing infrastructure.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If continuous treatment downhole through capillary string is used, then asphaltene inhibitors can be delivered continuously, but large amounts of inhibitor are consumed and portions of the reservoir remain untreated

Engineering Contradiction:
Improveasphaltene inhibition effectivenessVSAvoidinhibitor consumption
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The treatment is divided into discrete nanoparticle packets distributed throughout the reservoir rather than continuous injection through capillary string. Each nanoparticle packet contains encapsulated inhibitor that releases locally, segmenting the treatment into multiple independent action points that collectively cover the entire reservoir volume.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The inhibitor is pre-loaded into nanoparticle carriers before injection, allowing the treatment to be delivered in a single or limited number of injections rather than requiring continuous replenishment. The nanoparticles are prepared in advance with the inhibitor encapsulated, ready for immediate release upon contact with formation fluids.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If continuous treatment downhole through capillary string is used, then asphaltene inhibitors can be delivered continuously, but extensive infrastructure is required that is not easily retrofitted

Engineering Contradiction:
Improveasphaltene inhibition effectivenessVSAvoidtreatment infrastructure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The complex continuous injection infrastructure (capillary strings, pumps, control systems) is removed and replaced with simple nanoparticle injection through existing wellbores. The treatment function is extracted from the infrastructure and embedded in the nanoparticle carriers themselves, which provide sustained release without requiring continuous mechanical injection systems.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The nanoparticles provide self-regulated inhibitor release through their encapsulation structure, eliminating the need for external control systems, pumps, and monitoring infrastructure. The nanoparticles automatically release inhibitor in response to formation conditions (temperature, pressure, fluid contact), making the system self-regulating and infrastructure-independent.

Inventive Principle:
Principle #25Self-service

3Reliability

If conventional asphaltene inhibitors are used, then treatment can be applied, but frequent re-treatment is required increasing costs and production interruption

Engineering Contradiction:
Improveasphaltene inhibition effectivenessVSAvoidtreatment duration
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The nanoparticle encapsulation structure provides continuous inhibitor release over extended periods (months to years) as formation fluids pass through the reservoir. The gradual release mechanism maintains effective inhibitor concentration continuously along the flow path, eliminating the gaps between re-treatments that occur with conventional methods.

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The release rate and duration are controlled by modifying nanoparticle parameters such as shell thickness, material composition, and pore structure. These parameter changes enable tuning of the release profile to match production rates and extend treatment duration without requiring chemical formulation changes or re-injection.

Inventive Principle:
Principle #35Parameter changes

4Ease of manufacture

If squeeze treatment is used with nanoparticles, then existing infrastructure can be utilized, but proper nanoparticle design is required for effective retention and release

Engineering Contradiction:
Improvedeployment simplicityVSAvoidnanoparticle design requirements
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The nanoparticle structure incorporates local quality variations with different functional zones: a hydrophobic core for inhibitor solubility, a porous shell for controlled release, and surface modifications for retention in the reservoir. Each region of the nanoparticle is optimized for its specific function, enabling effective performance while maintaining manufacturability through standardized synthesis protocols.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The nanoparticles enable sustained release of asphaltene inhibitors, reducing treatment frequency and costs, ensuring comprehensive protection of subterranean formations and wells, and avoiding the need for continuous treatment processes.

Implementation Method 1

The nanoparticle can be structured such that it is capable of releasing the asphaltene inhibitor(s) over prolonged or extended periods of time

Methodology Applied
Scientific EffectDiffusion: Diffusion

Implementation Method 2

The asphaltene inhibitor can be impregnated within the nanoparticle, and/or can be bound or otherwise adhered on at least a portion of an outer surface of the nanoparticle

Methodology Applied
Scientific EffectDissolution:

Data Source

PatentUS12404439B2Extended release asphaltene inhibitor composition
Publication Date: 2025.09.02 CHAMPIONX LLC
  • US12404439B2 patent drawing
  • US12404439B2 patent drawing
  • US12404439B2 patent drawing

AI summary

A nanoparticle for well-treatment applications and compositions and methods of making and using the same can include a carrier material and an asphaltene inhibitor. The asphaltene inhibitor is capable of being released from the carrier material. The nanoparticle can have a size of 10 nanometers (nm) to 500 nm.